Immediate Impact
4 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
2023 Standout
Works of Nicolas Madranges being referenced
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity
2012
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Nicolas Madranges | 65 | 37 | 21 | 11 | 78 | |
| Timothy F. Goggins | 50 | 20 | 11 | 12 | 88 | |
| Shruti Tiwari | 64 | 30 | 17 | 10 | 100 | |
| Christian S. Adonizio | 52 | 29 | 17 | 11 | 100 | |
| C. Tosello | 77 | 22 | 42 | 9 | 94 | |
| Luca Paruzzo | 83 | 30 | 22 | 11 | 165 | |
| J.J. Soto Castillo | 35 | 24 | 9 | 13 | 96 | |
| Edward Y. Zhu | 28 | 26 | 24 | 13 | 71 | |
| Roberto Di Cicilia | 31 | 22 | 17 | 14 | 61 | |
| Lindsay A. Bernardo | 47 | 65 | 16 | 7 | 93 | |
| Punam Rana | 52 | 25 | 14 | 9 | 101 |
All Works
Loading papers...